|
⚲
|
| Keyboard |
| Bain Capital Public Equity LP
✚
|
|
|---|---|
| CRD # | 145650 |
| SEC # | 801-69070 |
| CIK # | 0001962552, 0001156175 |
| AUM | 242.2 M (2026-03-31) |
| Employees | 26 (15% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 617-516-2318 |
| Address | 200 Clarendon Street Boston, MA 02116 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5. Fees and Compensation
Fees
As compensation for investment advisory services rendered to the Public Equity Clients, Bain
Capital Public Equity receives from applicable Public Equity Clients an annual management fee
payable quarterly in advance. Certain vehicles also pay management fees on a monthly basis.
Personnel of Bain Capital Public Equity and its affiliates are largely exempt from paying
management fees. Upon the termination of an Advisory Agreement, appropriate treatment,
including, where applicable, returning prepaid management fees on a prorated basis, will be
given to all fees collected in advance. Management fees paid by a Public Equity Client are
indirectly borne by the investors in such Public Equity Client.
The precise amount of, and the manner and calculation of, the management fee for each Public
Equity Fund is established by Bain Capital Public Equity and set forth in such Public Equity ’s
Advisory Agreement, governing documents and/or other documentation received by each
investor prior to investment in such Public Equity Fund. The fee structures described above may
be modified from time to time.
Fees differ from one Public Equity Client to another, as well as among investors in the same
Public Equity Client. In its sole discretion, Bain Capital Public Equity may waive or reduce
management fees, including for certain investors.
Expenses
The Public Equity Clients generally bear their own expenses. These expenses may vary among
Public Equity Clients and are subject to the terms and conditions set forth in the applicable Public
Equity Client’s offering materials, governing documents, or other analogous organizational
documents. The expenses generally borne by Public Equity Funds are outlined below.
Unless otherwise specified herein or in such Public Equity Fund’s organizational documents, each
eligible Public Equity Fund bears its organizational, operational, and offering expenses and
obligations (which include):
(a) all out-of-pocket expenses incurred in connection with organizing and establishing the
Public Equity Fund and the General Partner, offering interests in the Public Equity Fund
(including legal and accounting expenses, filing fees and expenses, travel,
accommodation and related expenses, printing costs or any other expenses incurred with
respect to the offering) (“Organizational Expenses”);
(b) all investment-related expenses (including any such expenses incurred in connection with
potential investments, whether or not completed), including: expenses relating to
identifying, discovering, sourcing, developing (including any retainers, success and
finder’s fees and other compensation paid to contractors, senior advisers and sourcing
and operating partners), evaluating, valuing, researching, investigating, structuring
(including rating agency fees and expenses), diligencing, monitoring, maintaining,
purchasing, making, holding, acquiring, registering (including notary and “gestoria” costs),
selling (or potentially selling), or restructuring investments (whether or not completed,
including broken deal and reverse break-up fees, liquidated damages, forfeited deposits,
reverse termination fees or similar payments); all lodging, travel, transportation (including
the use of charter, first class or business travel and taxis and car rentals and any other
transportation), meals, and related expenses (including any of these incurred by an
investment team or other member of the General Partner or Bain Capital Public Equity or
their affiliates) incurred in connection with the Public Equity Funds’ affairs, and with
evaluating, making and monitoring investments; professional costs and expenses
(including legal, compliance, tax, financial, accounting, actuarial, valuation, advisory and
consulting/experts (including consultants or experts for industry-specific matters, due
diligence, reference checks, sourcing or introductions and other similar costs)); brokerage
commissions, hedging costs, expenses relating to short sales, prime brokerage fees,
financing costs and expenses, custodial expenses, clearing and settlement charges,
private placement fees, syndication fees, solicitation fees, arranger fees, sales
commissions, pricing and valuation fees (including appraisal fees), underwriting
commissions and discounts, investment banking fees, advisory fees (including income-
based repayments, receivership costs and similar fees and costs), and bank charges, and
custodial, trustee, transfer agent, recordkeeping and other administrative costs; fees of
third- party experts or consultants; and value-added taxes and taxes incurred in
connection with investments;
(c) all expenses of the Public Equity Funds incurred in connection with the ongoing operation
and administration of the Public Equity Funds, including: any legal, tax, auditing,
accounting and consulting fees, bookkeeping, record keeping, environmental, social, and
governance (“ESG”), procurement, cybersecurity, and clerical services to the Public Equity
Funds;
(d) fees, taxes and expenses associated with the Public Equity Funds’ audits and financial
statements (including fees and expenses associated with preparing tax information,
returns and elections), including fees and expenses associated with preparing, filing or
distributing tax information, returns or elections and complying with any tax audit,
investigation, settlement or review; expenses incurred in connection with the preparation
and maintenance of the Public Equity Funds’ books and records and account holder
diligence; expenses incurred in connection with the preparation and delivery of wires and
distributions, financial and other reports, circulars, forms, notices, valuations, investment
... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7. Types of Clients Bain Capital Public Equity currently provides investment advisory services to the Public Equity Funds. Investment advice is provided directly to the Public Equity Funds, subject to the direction and control of the General Partner of such Public Equity Fund, and not individually to the Limited Partners of such Public Equity Fund. As noted, Bain Capital Public Equity also sub-advises a UCITs. Except for the UCITS and BCEOF, interests in the Public Equity Funds are offered pursuant to applicable exemptions from registration under the Securities Act and the 1940 Act. Investors in the Public Equity Funds include high net worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities. Bain Capital Public Equity does not impose minimum dollar values on creating a Public Equity Fund; however legal eligibility requirements must be met and minimum investment commitments may be established for Limited Partners in the Public Equity Funds. The General Partner of each Public Equity Fund, in its sole discretion, may permit investments below the required minimum investment commitments. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Alcoa Inc | 0.0 | ||
| Taiwan Semiconductor Manufacturing Co Ltd | 0.0 | ||
| Amazon Com Inc | 0.0 | ||
| Apple Inc | 0.0 | ||
| Performance Food Group Co | 0.0 | ||
| Hubbell Inc | 0.0 | ||
| Banco Santander Sa | 0.0 | ||
| Netflix Inc | 0.0 | ||
| Live Nation Entertainment Inc | 0.0 | ||
| Burlington Stores Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Bain Capital Public Equity Enduring Equity Fund LP | [2023-02-17] | 455.0 M | 575.0 M |
| Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| Other | Bain Capital Public Equity Coinvest IV LP | 2022-02-16 | 21.4 M | |
| Other | Bain Capital Public Equity Coinvest III LP | 2020-07-07 | 27.6 M | |
| Other | Bain Capital Public Equity Coinvest II LP | 2020-07-07 | 1.1 M | |
| HF | Bain Capital Public Equity Global Long Equity Fund LP | 2020-02-21 | 1,184.6 M | |
| Other | Bain Capital Public Equity Coinvest Docusign LP | 2018-03-30 | 27.6 M | |
| HF | Bain Capital Public Equity Global Partners Fund LP | [2017-09-29] | 514.7 M | 155.9 M |
| Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Bain Capital Public Equity Global Industrials Fund LP | [2017-07-12] | 209.7 M | 255.1 M |
| Filed 2019-05-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Brookside Capital Partners Fund III LP | 2015-02-26 | 134.2 M | |
| HF | Brookside Capital Partners Fund II LP | [2012-03-30] | 975.5 M | 112.6 M |
| Filed 2017-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Brookside Capital Partners Fund II Offshore LP | 2012-03-30 | 35.8 M | |
| HF | Brookside Capital Partners Fund LP | 2012-03-30 | 917.4 M | |
| HF | Brookside Capital Trading Fund LP | 2012-03-30 | 1,470.5 M | |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 0.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 0.2 |
| By Discretionary | ||
| Discretionary | 4 | 0.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 0.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.2 | |
| Total | 4 | 0.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Michael Treisman | Director, Executive Officer | 57 | 6 | |
| Kathleen Rockey | Executive Officer | 69 | 5 | |
| Andrew Viens | Director, Executive Officer | 60 | 5 | |
| Sean Doherty | Executive Officer | 41 | 5 | |
| Michael Goss | Executive Officer | 26 | 5 | |
| Sally Dornaus | Executive Officer | 69 | 4 | |
| Mark Moore | Executive Officer | 32 | 4 | |
| Ranesh Ramanathan | Director, Executive Officer | 33 | 3 | |
| Adam Koppel | Executive Officer | 23 | 3 | |
| Colin Campbell | Executive Officer | 17 | 3 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001156175] | |
| 3 | [0001156175] | |
| 4 | [0001156175] | |
| 5 | [0001156175] | |
| SC 13G | [0001156175] | |
| 13F-HR | [0001962552] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $10.5B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 6UYOOZUIKHTN7U75ZV92 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mulesoft Inc MULE
Class A Common Stock
|
2017-04-04 | Sell | 10,855 | $23.85 | 258,892 |
|
Mulesoft Inc MULE
Class A Common Stock
|
2017-03-17 | Buy | 500,000 | $17.00 | 8,500,000 |
|
Mulesoft Inc MULE
Class A Common Stock
|
2017-03-17 | Buy | 203,082 | $25.06 | 5,089,235 |
|
Mulesoft Inc MULE
Class B Common Stock · derivative
|
2017-03-17 | Conversion | 890,689 | ||
|
Mulesoft Inc MULE
Series G Convertible Preferred Stock · derivative
|
2017-03-17 | Conversion | 890,689 | ||
|
Radius Health Inc NONE
Common Stock
|
2014-06-05 | Buy | 500,000 | $8.00 | 4,000,000 |
|
Radius Health Inc NONE
Common Stock Warrants · derivative
|
2014-03-28 | Buy | 67,160 | $6.14 | 412,362 |
|
Radius Health Inc NONE
Series B-2 Convertible Preferred Stock · derivative
|
2014-03-28 | Buy | 26,684 | $61.42 | 1,638,931 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-18 | Sell | 14,937 | $38.62 | 576,867 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-18 | Sell | 250,000 | $37.75 | 9,437,500 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-17 | Sell | 9,301 | $36.50 | 339,486 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-14 | Sell | 50,400 | $35.33 | 1,780,632 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-14 | Sell | 200,000 | $35.50 | 7,100,000 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-12 | Sell | 1,500 | $37.77 | 56,655 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-11 | Sell | 2,900 | $38.37 | 111,273 |
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2014-03-11 | Sell | 257,100 | $38.00 | 9,769,800 |
|
Concert Pharmaceuticals Inc CNCE
SERIES B CONVERTIBLE PREFERRED STOCK · derivative
|
2014-02-19 | Conversion | 4,300,000 | $0.00 | |
|
Concert Pharmaceuticals Inc CNCE
COMMON STOCK
|
2014-02-19 | Buy | 350,000 | $14.00 | 4,900,000 |
|
Concert Pharmaceuticals Inc CNCE
COMMON STOCK
|
2014-02-19 | Conversion | 761,062 | ||
|
Concert Pharmaceuticals Inc CNCE
SERIES C CONVERTIBLE PREFERRED STOCK · derivative
|
2014-02-19 | Conversion | 2,000,000 | $0.00 | |
| showing 20 of 27 most recent transactions | |||||
| Related Firms | State | AUM |
|---|---|---|
|
Bain Capital Private Equity LP
✚
|
MA | 96.43 B |
|
Bain Capital Credit LP
✚
|
MA | 76.30 B |
|
Bain Capital Real Estate LP
✚
|
MA | 9,995.4 M |
|
Bain Capital Ventures LP
✚
|
MA | 9,837.9 M |
|
BCSF Advisors LP
✚
|
MA | 3,647.4 M |
|
Bain Capital Partnership Strategies LP
✚
|
MA | 1,652.2 M |
|
Bain Capital Public Equity LP
✚
|
MA | 242.2 M |
|
Bain Capital Credit CLO Advisors LP
✚
|
MA |
| Comparable Firms | State | AUM |
|---|---|---|
|
Metronome Capital LLP
✚
|
244.9 M | |
|
Kultura Capital Management LP
✚
|
UT | 244.7 M |
|
Bandera Partners LLC
✚
|
NY | 244.1 M |
|
ShoreVest Partners Ltd
✚
|
244.0 M | |
|
Little Harbor Advisors LLC
✚
|
MA | 242.6 M |
|
DFN Management LLC
✚
|
FL | 241.4 M |
|
Tenere Capital LLC
✚
|
NY | 241.1 M |
|
English Capital Management LLC
✚
|
MI | 241.1 M |
|
Armatus Capital Management LLC
✚
|
241.0 M | |
|
Clearfield Capital Management LP
✚
|
NY | 240.2 M |